Lowering Fair Value Estimate on Nvidia Stock
Although we like the company's AI and gaming prospects, shares remain overpriced after ARM deal falls apart.
Although we like the company's AI and gaming prospects, shares remain overpriced after ARM deal falls apart.
On Feb. 7, Nvidia (NVDA) and SoftBank announced the termination of Nvidia's acquisition of ARM from SoftBank due to significant regulatory hurdles. Regulators in the U.S., U.K., and E.U. have been concerned the combination would be anticompetitive. Specifically, due to the importance of ARM technology in nearly every smartphone and increasingly other compute applications, Nvidia's ownership of ARM could have lead to higher prices or curb innovation for future technologies. We suspect major ARM customers such as Qualcomm, Microsoft, Apple, and others were also opposed to the deal, as it threatened ARM's status as a relatively independent and vital cog in the broader semiconductor ecosystem. SoftBank will receive a break-up fee of $1.25 billion, and the technology conglomerate will re-IPO ARM. We are lowering our fair value estimate for wide-moat Nvidia to our standalone fair value of $187 per share (from $194 per share on a probability-adjusted basis). Shares look overvalued at current levels.
The initial timeline for Nvidia to receive regulatory clearances in the U.S., U.K., E.U., China, and other jurisdictions was roughly 18 months (i.e., early 2022). We had been fairly skeptical of the deal going through and are not surprised that Nvidia balked at the increased scrutiny. However, we don't think Nvidia's future prospects are greatly curtailed without ARM. Nvidia's GPU dominance in gaming and data centers remains unparalleled, and it can easily license ARM designs for its future server CPU aspirations without having to acquire ARM. The firm already licenses ARM designs for parts of its self-driving platform, Nintendo Switch chips, Mellanox networking products, data processing units, and upcoming server CPUs. Owning ARM could theoretically have given Nvidia an unfair edge in the markets these chips are sold into.
Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days. |
Abhinav Davuluri does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.